Investor Presentation
GERRESHEIMER
Further Capacity Increase for Vials and Syringes Fully Ongoing
Gx as Reliable Partner for Pharma and Healthcare
Growing injectables market as
global mega trend
■ Vaccination as global
mega trend
Covid-19 is expected to
boost the market
Therapeutics are switching
from chemical to biological
Recurrent vaccination
increases demand
for syringes
Clearly standing by
our responsibility
Assumption for Covid-19
vials proving conservative
Global demand of 2-3bn
units for Covid-19
vaccination in 2021/2022
Customers demanding
single and multi-dose vials
At least 800m units foreseen
to be delivered over the next
two years
Capacity increase to serve
global demand
Investments brought forward:
Vials: New machines being
installed, including new RTF
vials machine in Buende
Syringes: RTF 5 line
ramping up, RTF 6 line to
start production mid-2021
13.10.2020
Investor Presentation
18
18View entire presentation